Medtronic faces a serious recall related to battery issues with its automated insulin delivery systems. Our sister site, Drug Delivery Business News, reports today that the company issued a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin pumps. The medtech giant identified an issue in which physical impact to the […]
Drug Pumps
ICU Medical appoints new president
ICU Medical announced that it appointed Daniel Woolson as the new president of the company, effective immediately. On Sept. 30, the company’s board appointed Woolson, 48, to the position. He has served as corporate VP and GM for Infusion Systems at ICU Medical since 2017. Before joining ICU Medical, Woolson served as president of Respiratory […]
Embecta wins FDA clearance for disposable insulin patch pump
Embecta (Nasdaq:EMBC) today entered the insulin patch pump market with a major regulatory milestone. Our sister site, Drug Delivery Business News, reports that the company received FDA clearance for its proprietary disposable insulin delivery system. The system caters to both the type 1 and type 2 diabetes populations. Clearance marks another regulatory milestone for patch pumps […]
FDA clears Insulet Omnipod 5 for people with type 2 diabetes
Insulet today picked up an FDA nod that expands the addressable patient population for its automated insulin delivery technology. Our sister site, Drug Delivery Business News, reports that the FDA cleared the Omnipod 5 system for the type 2 diabetes population. The Acton, Massachusetts-based company said in June that it submitted study results to the FDA […]
The 9 largest diabetes tech companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Insulet reports Omnipod sales growth of 26% in Q2, raises guidance despite EPS miss
Insulet stock is down on second-quarter results that came in mixed compared to the consensus forecast. Our sibling site, Drug Delivery Business News, has the latest today on the company’s second-quarter earnings report, which Insulet released yesterday evening. Shares of PODD were down more than 7% to $184.56 apiece by midday trading today. MassDevice’s MedTech 100 Index […]
Abbott, Medtronic partner to connect CGM, insulin delivery systems
Abbott and Medtronic today announced a major partnership in the diabetes technology space. Our sibling site, Drug Delivery Business News, reported today that the companies agreed to a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems. Abbott and Medtronic want to collaborate on a system based on Abbott’s FreeStyle Libre continuous glucose monitors (CGMs) with […]
Tandem Diabetes Care integrates t:slim X2 with Dexcom CGMs in Canada
Tandem Diabetes Care (Nasdaq:TNDM) continues to expand its diabetes treatment partnership with Dexcom (Nasdaq:DXCM). Our sibling site, Drug Delivery Business News, reported today that Tandem has launched its updated t:slim X2 insulin pump software with Dexcom CGMs in Canada. San Diego–based Tandem now offers the t:slim X2 pump software with the Dexcom G6 and G7 continuous glucose […]
Koru Medical Systems eliminates chief technology officer position, fills COO role
Koru Medical Systems today announced it eliminated its chief technology officer role and hired someone to fill the newly created chief operating officer position. The Mahwah, N.J.-based infusion pump developer announced in an SEC filing that, as of July 18, the Board of Directors eliminated the position of chief technology officer, which Brian Case […]
Embecta stock rises on reports that it might look to sell
Financial Times reports that Embecta (Nasdaq:EMBC), the former diabetes unit at BD, hired advisers to look into a possible sale of the company. Shares of EMBC ticked up 16.5% to $15.34 apiece in early-morning trading today. The company has operated as a standalone, publicly-traded company since April 2022, when it completed its spin-off from BD. […]
Diabeloop study highlights disparities in insulin requirements between sexes
Diabeloop reported results from a real-world study that demonstrated important differences between males and females in insulin requirements. The study evaluated more than 9,000 adults with type 1 diabetes across Europe. It utilized data from patients using the Diabeloop Generation 1 (DBLG1) hybrid closed-loop insulin delivery device. Investigators published findings in the Journal of Diabetes […]
